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Short Communication
Decreased natural killer cell activity and interferon
production by leucocytes in patients with adenocarcinoma of
the pancreas
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University of Uppsala, Uppsala, Sweden
Natural killer (NK) cells may play an important
role in immune surveillance against tumours
(Herberman, 1982) and interferons (IFN) may serve
as modulators of their cytolytic activity (Bloom,
1980). Diminished NK activities of peripheral blood
leucocytes (PBL) have been reported in patients
with advanced cancers (Pross & Baines, 1976;
Takasugi et al., 1977; Kadish et al., 1981; Steinhauer
et al., 1982). This may be due to reduced sensitivity
of NK cells to IFN or to impaired IFN production.
It has been reported that in vitro preincubation of
PBL with IFN largely restores NK activity in some,
but not all cancer patients, and that the in vitro
production of IFN by PBL is normal (Kadish et al.,
1981). On the other hand, we found that PBL from
patients with mid-gut carcinoids were selectively
deficient with respect to production of pH2 labile
IFN-a after stimulation by Staphylococcus aureus
Cowan I (SACoI), while basal and IFN-enhanced
NK activities did not differ from those of the
controls (Funa et al., 1983). To further explore
cancer-associated deficiencies in the NK-IFN
system, we have investigated a group of patients
with adenocarcinoma of the pancreas.
We studied seven patients aged 53 to 76 years
(median age 62 years) with pancreatic
adenocarcinoma (3 with verified liver metastases
and 4 with local extra-pancreatic tumour
infiltration), before surgery. As a control group were
used 13 healthy blood donors aged 20 to 70 years
(median age 61 years). PBL were prepared from
heparinized venous blood by centrifugation on
Ficoll-Hypaque as described elsewhere (Funa et al.,
1983). The PBL were resuspended in RPMI 1640
medium, supplemented with 5% heat inactivated
foetal calf serum (FCS; Flow Laboratories),
100Uml- penicillin, 100jgml-l streptomycin and
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2mM L-glutamine. NK sensitive human
erythroleukaemia K 562 cells were used as targets in
short term (3h) "Cr release assays, performed as
described previously (Funa et al., 1983). Percent
specific lysis was calculated with the formula:
Spcific lysis -Exp. release -Spont. release 100
Max. release-Spont. release
Cytotoxicity was expressed as lytic units (LU),
which were calculated by multiplying by 1000 the
inverted ratio of effector to target cells at which
20% specific lysis occurs.
For in vitro activation by IFN, PBL were
incubated for 1 h with equal volumes of two-fold
dilutions of partially purified Sendai virus-induced
leucocyte IFN-cx (Interferon Laboratory,
University Hospital, Uppsala, Sweden), starting
with 1600Uml' before addition of labelled K562
target cells. Effector:target cell ratio was 50:1. The
cytotoxicity was determined as described above.
The percentage of specific lysis was plotted against
logl0 IFN concentration (latter on x axis).
Regression analyses were performed for each assay
using the equation: y=a+blog,0x. The slopes of
the regression lines (the b coefficients in the
regression equation) indicate sensitivities of NK
cells to IFN (Funa et al., 1983).
The IFN-producing capacity was determined by
incubating PBL with the inducers SACoI (1/1000
v/v), Concanavalin A (ConA; 20pgml -1), Lens
culinaris lectin (LCL; 100pgml), and Sendai virus
(5000 haemagglutinin Uml-P chorioallantoic fluid).
PBL were cultured at a density of 4 x 101 cells in
0.2ml per well in flat-bottomed microtitre-plates
(Nunc, Roskilde, Denmark) at 37°C in 5% CO2 in
air. After 48h, supernatants were collected from
each well for IFN assay. The supernatants with
Sendai virus were dialysed against pH2 buffer
before IFN assay to inactivate the virus. A
conventional cytopathic effect inhibition assay on
human amnion WISH cells was used to measure
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the antiviral activity in culture supernatants as
previously described (Funa et al., 1983), with
vesicular stomatitis virus as challenging virus. All
antiviral activities were expressed as IFN-a units
per ml using a standard IFN-cx (G-023-901-527;
NIH, Bethesda, MD) as reference.
The in vitro IFN production by PBL is shown
in Figure 1. A diminished IFN production was
found in patients when SACoI was used as in-
ducer (median test with Fisher exact probability:
P=0.024). No significant differences were seen
between PBL of patients and controls with the
IFN-y inducers ConA (Fisher P=0.31) and LCL
(P=0.073), and the IFN-a inducer Sendai virus
(P=0.48). Cytotoxicity against K562 cells in patients
(median: 10LU, n=7) was significantly lower than
that of the control subjects (median: 42LU, n=13;
median test with Fisher P=0.027), as shown in
Figure 1. The sensitivity of NK cells to in vitro IFN
as measured by the slopes of regression lines (b
coefficients) was significantly higher in control PBL
than in patients' PBL (t-test with equal variances:
t=3.30, df= 18, P=0.008) (shown in Figure 2).
The present study shows that patients with
pancreatic adenocarcinoma have both a decreased
basal NK activity and a decreased in vitro reponse
of NK cells to IFN-a. There are several reports of
reduced basal NK levels in PBL of patients with
disseminated cancers (Pross & Baines, 1976; Kadish
et al., 1981), and evidence exists that the defect
resides in the reduced ability of NK cells to recycle
the cytolytic process, while the number of NK cells
may be normal (Steinhauer et al., 1982). Suppressor
cells for NK activity have also been found in some
tumour-bearing individuals (Eremin, 1980; Gerson,
1980). Suppressor activity can be mediated by
prostaglandins produced by monocytes-
macrophages (Droller et al., 1978; Koren et al.,
1981).
Our patients showed an impaired ability to
produce IFN upon stimulation with SACoI while
normal productions were demonstrated for the
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Figure 1 IFN production and basal NK activity of PBL of patients with pancreatic adenocarcinomas (P;
filled circles) and of controls (C; open circles). Inducers used in culture were Concanavalin A (ConA), Lens
culinaris lectin (LCL), Staphylococcus aureus Cowan I (SACoI) and Sendai virus. The IFN concentrations
were expressed as Uml'-. NK activities were expressed as lytic units (LU).
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Figure 2 NK activities (percent specific lysis, mean
±SEM) after in vitro incubation of PBL with various
concentrations of IFN-a (Uml- 1). The slopes of
regression lines as calculated by dose response curves
were taken to measure NK cell sensitivity to IFN
(patients: y=9.5+3.1 x, r=0.961, n=7, P<0.0001;
controls: y=28.1+7.3 x, r=0.975, n=13, P<0.0001).
The averaged r values (±SD) from the individual
observations were 0.721 ±0.248 (n=7 patients) and
0.806+0.126 (n= 13 controls).
other IFN inducers, i.e., two T-cell mitogens that
induce IFN-y and Sendai virus that induce acid-
stable IFN-a. A similar selective deficiency of IFN
production by SACoI was seen in patients with
another type of gastrointestinal cancer, mid-gut
carcinoid (Funa et al., 1983). This SACoI-induced
IFN was first assumed to be acid-labile, IFN-a
(Funa et al., 1983), but further studies added the
information that this IFN is neutralized not only by
anti-IFN-a antibodies, but also frequently by anti-
IFN-y antibodies. This IFN appears to be produced
by null lymphocytes that in certain respects
resemble typical NK cells but do not carry same
spectrum of antigenic markers (Funa et al., to be
published). The nature and significance of the
observed deficiency in the SACoI-induced IFN
production remains to be established.
In conclusion, patients with pancreatic
adenocarcinomas, even with relatively localized
tumour burdens, showed deficiencies in the NK-
IFN system at at least three levels: (1) diminished
basal NK activities, (2) a decreased sensitivity of
such cells to IFN in vitro, and, (3) a decreased
atypical IFN production by SACol. In the in vivo
situation, these defects may be additive or even
synergistic, and, assuming a role for NK cells and
IFN in tumour resistance, may contribute to the
rapidly invasive and metastatic growth of
pancreatic adenocarcinomas.
This study was supported by grants from the Swedish
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